Home > Cashflow Statement > GLAND PHARMA

GLAND PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹-417 Cr₹-433 Cr₹-799 Cr₹15 Cr₹35 Cr

What is the latest Cash Flow from Financing Activities ratio of GLAND PHARMA ?

The latest Cash Flow from Financing Activities ratio of GLAND PHARMA is ₹-417 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹-417 Cr
Mar2025₹-433 Cr
Mar2024₹-799 Cr
Mar2023₹15 Cr
Mar2022₹35 Cr

How is Cash Flow from Financing Activities of GLAND PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹-417 Cr
Negative
Mar2025 ₹-433 Cr
Negative
Mar2024 ₹-799 Cr
Negative
Mar2023 ₹15 Cr
-57.25
Mar2022 ₹35 Cr -

Compare Cash Flow from Financing Activities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹48,224.6 Cr -1.7% -1.5% 57.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,958.0 Cr -3% -5.2% 17.9% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 0.2% 9.7% 56.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,233.0 Cr 1.3% 2% 36.5% Stock Analytics
CIPLA ₹110,273.0 Cr -2.2% -6.6% -10.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,906.4 Cr 1.4% -3.7% -8.8% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-1.7%

-1.5%

57.8%

SENSEX

-2.3%

-4.1%

-7.4%


You may also like the below Video Courses